Kenvue CEO Thibaut Mongon has stepped down as the company’s chief executive and departed its board of directors. The CEO of ...

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

Kenvue shares were up by more than 6% during pre-market on the back of the announcement. Board director Kirk Perry has been named interim CEO while the company undergoes a strategic review aimed at ...

Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson & Johnson. J&J ...

Kenvue says it will update shareholders as the strategic review progresses. Merlo added, “We are confident that the steps we are taking put Kenvue on the right path to deliver both near- and ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, named director Kirk Perry as interim chief executive officer as Thibaut Mongon departs the company.

Tylenol maker Kenvue ousts CEO amid board's strategic review By Sriparna Roy and Abigail Summerville July 14, 20252:07 PM PDTUpdated July 14, 2025 ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena ...